[go: up one dir, main page]

NO931627L - Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika - Google Patents

Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika

Info

Publication number
NO931627L
NO931627L NO93931627A NO931627A NO931627L NO 931627 L NO931627 L NO 931627L NO 93931627 A NO93931627 A NO 93931627A NO 931627 A NO931627 A NO 931627A NO 931627 L NO931627 L NO 931627L
Authority
NO
Norway
Prior art keywords
heteroatic
tricyclic
therapeutics
relations
procedure
Prior art date
Application number
NO93931627A
Other languages
English (en)
Other versions
NO931627D0 (no
NO305865B1 (no
Inventor
Karl Baumann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO931627D0 publication Critical patent/NO931627D0/no
Publication of NO931627L publication Critical patent/NO931627L/no
Publication of NO305865B1 publication Critical patent/NO305865B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
NO931627A 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser NO305865B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (3)

Publication Number Publication Date
NO931627D0 NO931627D0 (no) 1993-05-05
NO931627L true NO931627L (no) 1993-11-08
NO305865B1 NO305865B1 (no) 1999-08-09

Family

ID=26300836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931627A NO305865B1 (no) 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser

Country Status (25)

Country Link
US (1) US5514685A (no)
EP (1) EP0569337B1 (no)
JP (1) JP2788392B2 (no)
KR (1) KR100292311B1 (no)
CN (1) CN1037773C (no)
AT (1) ATE155787T1 (no)
AU (1) AU668152B2 (no)
CA (1) CA2095659C (no)
CY (1) CY2126B1 (no)
CZ (1) CZ291773B6 (no)
DE (1) DE69312386T2 (no)
DK (1) DK0569337T3 (no)
ES (1) ES2105193T3 (no)
FI (2) FI102612B1 (no)
GR (1) GR3024754T3 (no)
HU (2) HUT66531A (no)
IL (1) IL105607A (no)
MY (1) MY109602A (no)
NO (1) NO305865B1 (no)
NZ (1) NZ247553A (no)
PH (1) PH30456A (no)
RU (1) RU2126009C1 (no)
SG (1) SG47011A1 (no)
SK (1) SK282061B6 (no)
TW (1) TW330936B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
KR100434682B1 (ko) 1994-10-26 2004-08-18 노바티스 아게 약학조성물
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
AU749623B2 (en) 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
WO2004009056A1 (en) 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
CN102958935B (zh) * 2010-04-02 2015-12-09 爱尔兰詹森科学公司 大环整合酶抑制剂
JPWO2016068208A1 (ja) 2014-10-28 2017-08-10 晃史 山口 妊娠状態を改善するための薬剤及びその利用
JP7465806B2 (ja) 2018-08-10 2024-04-11 晃史 山口 母体と胎児との関係における液性免疫関連疾患の治療薬
CA3123535A1 (en) 2018-12-18 2020-06-25 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
JPH04500372A (ja) * 1989-06-14 1992-01-23 サンド・リミテッド 異種原子含有三環式化合物
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
DE69232630T2 (de) * 1991-09-05 2003-10-09 Abbott Laboratories, Abbott Park Makrocyclische immunmodulatoren

Also Published As

Publication number Publication date
CA2095659A1 (en) 1993-11-08
KR100292311B1 (ko) 2001-09-17
FI932035A (fi) 1993-11-08
CA2095659C (en) 2005-08-09
JP2788392B2 (ja) 1998-08-20
MY109602A (en) 1997-03-31
DE69312386D1 (de) 1997-08-28
SK43593A3 (en) 1995-07-11
JPH0641144A (ja) 1994-02-15
AU668152B2 (en) 1996-04-26
US5514685A (en) 1996-05-07
AU3839393A (en) 1993-11-11
HU9301190D0 (en) 1993-07-28
SK282061B6 (sk) 2001-10-08
NO931627D0 (no) 1993-05-05
CZ291773B6 (cs) 2003-05-14
FI102612B (fi) 1999-01-15
TW330936B (en) 1998-05-01
FI102612B1 (fi) 1999-01-15
IL105607A (en) 1998-01-04
CY2126B1 (en) 2002-06-21
DE69312386T2 (de) 1998-01-29
RU2126009C1 (ru) 1999-02-10
SG47011A1 (en) 1998-03-20
EP0569337A1 (en) 1993-11-10
HUT66531A (en) 1994-12-28
ATE155787T1 (de) 1997-08-15
IL105607A0 (en) 1993-09-22
NZ247553A (en) 1995-07-26
GR3024754T3 (en) 1997-12-31
CN1083486A (zh) 1994-03-09
PH30456A (en) 1997-05-28
EP0569337B1 (en) 1997-07-23
KR940005631A (ko) 1994-03-22
CZ82993A3 (en) 1994-01-19
DK0569337T3 (da) 1998-01-19
CN1037773C (zh) 1998-03-18
ES2105193T3 (es) 1997-10-16
NO305865B1 (no) 1999-08-09
FI982476A0 (fi) 1998-11-16
HU211135A9 (en) 1995-10-30
FI932035A0 (fi) 1993-05-05

Similar Documents

Publication Publication Date Title
ITMI930699A0 (it) Nuovi derivati dell'indolo
NO931627D0 (no) Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
ATE159256T1 (de) Triazolopyrimidinderivate mit fungizider aktivität
PT626385E (pt) Derivados do tetra-hidropirano
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ES2094344T3 (es) Compuestos anti-virales.
EE9600057A (et) Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
NO178540C (no) Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
ES2053808T3 (es) Nuevos compuestos azolicos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees